Syme Colin A, Zhang Lei, Bisello Alessandro
Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, E1140 Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, Pennsylvania 15261, USA.
Mol Endocrinol. 2006 Dec;20(12):3400-11. doi: 10.1210/me.2006-0178. Epub 2006 Aug 24.
The glucagon-like peptide 1 receptor (GLP-1R) mediates important effects on beta-cell function and glucose homeostasis and is one of the most promising therapeutic targets for type 2, and possibly type 1, diabetes. Yet, little is known regarding the molecular and cellular mechanisms that regulate its function. Therefore, we examined the cellular trafficking of the GLP-1R and the relation between receptor localization and signaling activity. In resting human embryonic kidney 293 and insulinoma MIN6 cells, a fully functional green fluorescent protein-tagged GLP-1R was localized both at the cell membrane and in highly mobile intracellular compartments. Real-time confocal fluorescence microscopy allowed direct visualization of constitutive cycling of the receptor. Overexpression of K44A-dynamin increased the number of functional receptors at the cell membrane. Immunoprecipitation, sucrose sedimentation, and microscopy observations demonstrated that the GLP-1R localizes in lipid rafts and interacts with caveolin-1. This interaction is necessary for membrane localization of the GLP-1R, because overexpression of a dominant-negative form of caveolin-1 (P132L-cav1) or specific mutations within the putative GLP-1R's caveolin-1 binding domain completely inhibited GLP-1 binding and activity. Upon agonist stimulation, the GLP-1R underwent rapid and extensive endocytosis independently from arrestins but in association with caveolin-1. Finally, GLP-1R-stimulated activation of ERK1/2, which involves transactivation of epidermal growth factor receptors, required lipid raft integrity. In summary, the interaction of the GLP-1R with caveolin-1 regulates subcellular localization, trafficking, and signaling activity. This study provides further evidence of the key role of accessory proteins in specifying the cellular behavior of G protein-coupled receptors.
胰高血糖素样肽1受体(GLP-1R)介导对β细胞功能和葡萄糖稳态的重要作用,是2型糖尿病以及可能的1型糖尿病最有前景的治疗靶点之一。然而,关于调节其功能的分子和细胞机制知之甚少。因此,我们研究了GLP-1R的细胞转运以及受体定位与信号活性之间的关系。在静息的人胚肾293细胞和胰岛素瘤MIN6细胞中,一种功能完整的绿色荧光蛋白标记的GLP-1R定位于细胞膜和高度移动的细胞内区室。实时共聚焦荧光显微镜直接观察到了该受体的组成型循环。K44A-发动蛋白的过表达增加了细胞膜上功能性受体的数量。免疫沉淀、蔗糖沉降和显微镜观察表明,GLP-1R定位于脂筏并与小窝蛋白-1相互作用。这种相互作用对于GLP-1R的膜定位是必需的,因为小窝蛋白-1的显性负性形式(P132L-cav1)的过表达或假定的GLP-1R小窝蛋白-1结合域内的特定突变完全抑制了GLP-1的结合和活性。在激动剂刺激后,GLP-1R独立于抑制蛋白但与小窝蛋白-1相关联地经历快速而广泛的内吞作用。最后,GLP-1R刺激的细胞外信号调节激酶1/2(ERK1/2)激活,这涉及表皮生长因子受体的反式激活,需要脂筏完整性。总之,GLP-1R与小窝蛋白-1的相互作用调节亚细胞定位、转运和信号活性。这项研究进一步证明了辅助蛋白在确定G蛋白偶联受体的细胞行为中的关键作用。